Depigoid (Allerg.)

Depigoid(Allerg.) is a subcutaneous allergy treatment containing Dermatophagoides Pteronyssinus extract. It's designed to help manage allergic reactions by desensitizing the immune system. This polymerized extract is manufactured by Leti Pharma GmbH in the EU.

Depigoid(Allerg.) is used for the treatment of allergies, particularly those triggered by dust mites. It works by gradually reducing the body's sensitivity to allergens, helping to alleviate symptoms like sneezing, itching, and nasal congestion. This therapy is often considered for individuals who experience persistent allergic reactions.

Common effects of Depigoid(Allerg.) may include localized reactions at the injection site, such as redness, swelling, or itching. Some individuals might also experience temporary systemic reactions like fatigue or mild flu-like symptoms. These effects are generally mild and short-lived.

Depigoid(Allerg.) should be administered under medical supervision. It is important to inform your healthcare provider about any existing allergies or medical conditions before starting this treatment. Always follow the prescribed dosage and administration schedule to minimize potential risks.

Depigoid(Allerg.) may interact with certain medications, particularly those that affect the immune system. It is advisable to discuss all current medications with your healthcare provider to avoid potential interactions. Additionally, alcohol consumption should be moderated during treatment.